Pancreatic Cancer Research

ResearcherCentral South UniversityActive in the last 2 years

Zhen Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3038-3722; OpenAlex author ID A5075156758. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 4

  1. [Retracted] SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF‑κB pathway. Co-author DOI 10.3892/etm.2024.12751↗
  2. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer. Last author DOI 10.1002/mc.23668↗
  3. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells. Last author DOI 10.3389/fimmu.2023.1271603↗
  4. SIRT6 promotes ferroptosis and attenuates glycolysis in pancreatic cancer through regulation of the NF-κB pathway. Co-author DOI 10.3892/etm.2022.11430↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuangxi Gong · 2 shared papers, 2022–2025 · strength 0.46
  2. Jian Li · 2 shared papers, 2022–2025 · strength 0.46
  3. Qinghua Yin · 2 shared papers, 2022–2025 · strength 0.46
  4. Keping Deng · 1 shared paper, 2024 · strength 0.28
  5. Fang Zou · 1 shared paper, 2024 · strength 0.28
  6. Dayong Xu · 1 shared paper, 2024 · strength 0.28
  7. Zhenglin Ou · 1 shared paper, 2023 · strength 0.26
  8. Yebin Lu · 1 shared paper, 2023 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.